ITRM20030442A0 - Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. - Google Patents

Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Info

Publication number
ITRM20030442A0
ITRM20030442A0 IT2003RM000442A ITRM20030442A ITRM20030442A0 IT RM20030442 A0 ITRM20030442 A0 IT RM20030442A0 IT 2003RM000442 A IT2003RM000442 A IT 2003RM000442A IT RM20030442 A ITRM20030442 A IT RM20030442A IT RM20030442 A0 ITRM20030442 A0 IT RM20030442A0
Authority
IT
Italy
Prior art keywords
stressen
hyperhomocysteinemia
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
IT2003RM000442A
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ind Biochimiche Riuni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ind Biochimiche Riuni filed Critical Medosan Ind Biochimiche Riuni
Priority to IT000442A priority Critical patent/ITRM20030442A1/it
Publication of ITRM20030442A0 publication Critical patent/ITRM20030442A0/it
Priority to AT04104599T priority patent/ATE395055T1/de
Priority to DE602004013695T priority patent/DE602004013695D1/de
Priority to EP04104599A priority patent/EP1518554B1/en
Publication of ITRM20030442A1 publication Critical patent/ITRM20030442A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000442A 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. ITRM20030442A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
AT04104599T ATE395055T1 (de) 2003-09-26 2004-09-22 Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie
DE602004013695T DE602004013695D1 (de) 2003-09-26 2004-09-22 Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie
EP04104599A EP1518554B1 (en) 2003-09-26 2004-09-22 Pharmaceutical composition for the treatment of hyperhomocysteinemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Publications (2)

Publication Number Publication Date
ITRM20030442A0 true ITRM20030442A0 (it) 2003-09-26
ITRM20030442A1 ITRM20030442A1 (it) 2005-03-27

Family

ID=30131588

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Country Status (4)

Country Link
EP (1) EP1518554B1 (it)
AT (1) ATE395055T1 (it)
DE (1) DE602004013695D1 (it)
IT (1) ITRM20030442A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110847A1 (it) * 2011-05-13 2012-11-14 Soldato Piero Del Uso di un composto solforato per il trattamento di iperomocisteinemia e patologie correlate
CN105560264A (zh) * 2016-03-11 2016-05-11 广东伊茗药业有限公司 一种含腺苷钴胺的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
DE10004651A1 (de) * 2000-02-03 2001-08-16 Jutta Dierkes Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Also Published As

Publication number Publication date
EP1518554A1 (en) 2005-03-30
EP1518554B1 (en) 2008-05-14
DE602004013695D1 (de) 2008-06-26
ITRM20030442A1 (it) 2005-03-27
ATE395055T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
TWI350751B (en) Pharmaceutical compositions for treating diabetes
PT1501534E (pt) Formulacoes farmaceuticas
IS8275A (is) Píperasín afleiður til meðhöndlunar á HIV sýkingum
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
DK1587478T3 (da) Farmaceutisk sammensætning
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1596870T4 (da) Højdosis-ibandronatformulering
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
NO20034952D0 (no) Farmasöytiske forbindelser
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
ITMI20030346A1 (it) Procedimento per la produzione di mesitilene.
NL1025908A1 (nl) Farmaceutische combinatie.
ITMI20030826A1 (it) Composizione farmaceutica contenente interferone per il
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
NO20044164L (no) Farmasoytiske sammensetninger
DK2105135T3 (da) Farmaceutiske sammensætninger til behandling af cancer
ITRM20030053A1 (it) Associazione di farmaci antidiabetici.
DE112004001429D2 (de) Pharmazeutischer Wirkstoff